key: cord-0918229-1mpfxkdn
authors: Wong, Ho Yuen Frank; Lam, Hiu Yin Sonia; Fong, Ambrose Ho-Tung; Leung, Siu Ting; Chin, Thomas Wing-Yan; Lo, Christine Shing Yen; Lui, Macy Mei-Sze; Lee, Jonan Chun Yin; Chiu, Keith Wan-Hang; Chung, Tom; Lee, Elaine Yuen Phin; Wan, Eric Yuk Fai; Hung, Fan Ngai Ivan; Lam, Tina Poy Wing; Kuo, Michael; Ng, Ming-Yen
title: Frequency and Distribution of Chest Radiographic Findings in COVID-19 Positive Patients
date: 2020-03-27
journal: Radiology
DOI: 10.1148/radiol.2020201160
sha: 8b8034e56d7df4ff9b9f4231736b6d372fa80a81
doc_id: 918229
cord_uid: 1mpfxkdn

BACKGROUND: Current COVID-19 radiological literature is dominated by CT and a detailed description of chest x-ray (CXR) appearances in relation to the disease time course is lacking. PURPOSE: To describe the time course and severity of the CXR findings of COVID-19 and correlate these with real time reverse transcription polymerase chain reaction (RT-PCR) testing for SARS-Cov-2 nucleic acid. MATERIALS AND METHODS: Retrospective study of COVID-19 patients with RT-PCR confirmation and CXRs admitted across 4 hospitals evaluated between January and March 2020. Baseline and serial CXRs (total 255 CXRs) were reviewed along with RT-PCRs. Correlation with concurrent CTs (total 28 CTs) was made when available. Two radiologists scored each CXR in consensus for: consolidation, ground glass opacity (GGO), location and pleural fluid. A severity index was determined for each lung. The lung scores were summed to produce the final severity score. RESULTS: There were 64 patients (26 men, mean age 56±19 years). Of these, 58, 44 and 38 patients had positive initial RT-PCR (91%, [CI: 81-96%]), abnormal baseline CXR (69%, [CI: 56-80%]) and positive initial RT-PCR with abnormal baseline CXR (59 [CI:46-71%]) respectively. Six patients (9%) showed CXR abnormalities before eventually testing positive on RT-PCR. Sensitivity of initial RT-PCR (91% [95% CI: 83-97%]) was higher than baseline CXR (69% [95% CI: 56-80%]) (p = 0.009). Radiographic (mean 6 ± 5 days) and virologic recovery (mean 8 ± 6 days) were not significantly different (p= 0.33). Consolidation was the most common finding (30/64, 47%), followed by GGO (21/64, 33%). CXR abnormalities had a peripheral (26/64, 41%) and lower zone distribution (32/64, 50%) with bilateral involvement (32/64, 50%). Pleural effusion was uncommon (2/64, 3%). The severity of CXR findings peaked at 10-12 days from the date of symptom onset. CONCLUSION: Chest x-ray findings in COVID-19 patients frequently showed bilateral lower zone consolidation which peaked at 10-12 days from symptom onset.

I n P r e s s Background Current COVID-19 radiological literature is dominated by CT and a detailed description of chest x-ray (CXR) appearances in relation to the disease time course is lacking.

To describe the time course and severity of the CXR findings of COVID-19 and correlate these with real time reverse transcription polymerase chain reaction (RT-PCR) testing for SARS-Cov-2 nucleic acid.

Retrospective study of COVID-19 patients with RT-PCR confirmation and CXRs admitted across 4 hospitals evaluated between January and March 2020. Baseline and serial CXRs (total 255 CXRs) were reviewed along with RT-PCRs. Correlation with concurrent CTs (total 28 CTs) was made when available. Two radiologists scored each CXR in consensus for: consolidation, ground glass opacity (GGO), location and pleural fluid. A severity index was determined for each lung. The lung scores were summed to produce the final severity score.

There were 64 patients (26 men, mean age 5619 years). Of these, 58, 44 and 38 patients (p = 0.009). Radiographic (mean 6  5 days) and virologic recovery (mean 8  6 days) were not significantly different (p= 0.33). Consolidation was the most common finding (30/64, 47%), followed by GGO (21/64, 33%). CXR abnormalities had a peripheral (26/64, 41%) and lower zone distribution (32/64, 50%) with bilateral involvement (32/64, 50%). Pleural effusion was uncommon (2/64, 3%). The severity of CXR findings peaked at 10-12 days from the date of symptom onset.

The recent COVID-19 radiological literature is primarily focused on CT findings 5-10 , which is more sensitive than chest x-ray (CXR). In mainland China, CT was often a first-line investigation for COVID-19 11, 12 . However, this practice placed a huge burden on radiology departments and posed an immense challenge for infection control in the CT suite. Some hospitals in China dedicated specific CT scanners for examining suspected COVID-19 patients only 13 , a practice that is being instituted with difficulty in the United Kingdom 14 . The American

College of Radiology notes that CT decontamination required after scanning COVID-19 patients may disrupt radiological service availability, and suggests that portable chest x-ray (CXR) may be considered to minimize the risk of cross-infection 15 . Italian and British hospitals are beginning to employ CXR as a first-line triage tool due to long reverse transcription polymerase chain reaction (RT-PCR) turnaround times 14, 16 . Therefore, in some countries, CXR cannot be superseded by CT in the current pandemic. As the prevalence of COVID-19

increases, it is also imperative for clinicians of all specialties to recognize COVID-19 features on CXR that may be performed for other purposes.

To further our understanding of the radiographic features of COVID-19, our study aims to: (i) describe the chest x-ray appearances of COVID-19, (ii) correlate the chest x-ray appearances with reverse transcription polymerase chain reaction (RT-PCR), (iii) compare chest x-ray findings with CT findings, and (iv) describe the time course of chest x-ray appearances relative to symptom onset. 

A total of 64 patients from four tertiary and regional hospitals in Hong Kong (Queen Mary Hospital, Pamela Youde Nethersole Eastern Hospital, Queen Elizabeth Hospital, and Ruttonjee Hospital) were included from 1 st January 2020 to 5 th March 2020 (see figure 1 ). COVID-19 infection was confirmed by RT-PCR on nasopharyngeal swabs and throat swabs. Thirty-nine patients had serial RT-PCR results available at the time of writing. All patients had CXR upon admission, with follow-up CXRs available for all but one patient. Timing of symptom onset was obtained from public epidemiological data provided by the Hong Kong Center for Health Protection 17 . In the case of asymptomatic patients (9/64, 14%), date of first positive RT-PCR was substituted for symptom onset.

All CXRs were acquired as computed or digital radiographs following usual local protocols.

CXRs were acquired in the posteroanterior (PA) or anteroposterior (AP) projection. Follow-up CXRs were acquired in the AP projection using portable X-ray units. Over half of the CXRs at presentation were performed in the AP projection (36/64, 56%), with the rest in the PA projection. All follow-up CXRs were performed in the AP projection using portable X-ray units in the isolation wards. All CTs were acquired as non-contrast enhanced volumetric scans of the thorax at 1 to 1.25mm slice thickness following usual local protocols. HYSL and HYFW reviewed the CTs for presence or absence of consolidation and ground glass opacities.

To quantify the extent of infection, a severity score was calculated by adapting and simplifying the Radiographic Assessment of Lung Edema (RALE) score proposed by Warren et al. 19 A score of 0-4 was assigned to each lung depending on the extent of involvement by consolidation or GGO (0 = no involvement; 1 = <25%; 2 = 25-50%; 3 = 50-75%; 4 = >75% involvement). The scores for each lung were summed to produce the final severity score. Examples are given in 

The clinical characteristics of the 64 patients on presentation are summarized in Table 1 .

There were 26 males (41%) and 38 females (59%), with a mean age of 56 years (range 16 to I n P r e s s (14%) were asymptomatic. The most common co-morbidities were hypertension (20%) and diabetes (13%). Twenty-three patients had follow-up virologic recovery; 18 patients had follow up to chest xray recovery. The mean time from initial positive RT-PCR to negative RT-PCR was 87 days (n=23, range 1-24 days). The mean time from initial positive CXR to negative CXR was 65 days (n=18, range 1-18 days). Five patients never exhibited radiographic abnormalities and were not included in the radiographic recovery group. There was no statistically significant difference in the recovery time for RT-PCR and CXR recovery groups (p=0.33).

Twenty-eight of 64 patients (44%) in our cohort had CT performed within 48 hours of a CXR at a mean of 117 days (range 0-26 days) after symptom onset. Twenty-four of 28 patients had CXR severity scores >0, all of whom had positive findings on CT. Four patients had negative CXRs, of whom 3 had negative CTs as well, while 1 demonstrated ground glass opacities on CT (Figure 6 ).

The main feature of consolidation on chest x-ray in COVID-19 pneumonia is consistent with previously published case series 9, 21 . Of the 58 (58/64, 91%) patients who tested positive on initial RT-PCR, 38 (38/64, 59%) had abnormalities on baseline chest x-ray (CXR). Forty patients had abnormal baseline CXR. Six patients showed CXR abnormalities before eventually testing positive on RT-PCR. Sensitivity of initial RT-PCR (91% [95% CI: 83-97%]) was higher than that of baseline CXR (69% [95% CI: 56-80%]) (p = 0.009). Radiographic (mean 6  5 days) and virologic recovery (mean 8  7 days) were not significantly different (p= 0.33). Consolidation was the most common finding (30/64, 47%), followed by GGO (21/64, 33%). These had a peripheral (26/64, 41%) and lower zone distribution (32/64, 50%) with bilateral involvement (32/64, 50%). Pleural effusion was not common (2/64, 3%). The severity of CXR findings peaked at 10-12 days from the date of symptom onset.

We demonstrated that the common CT findings of bilateral involvement, peripheral distribution, and lower zone dominance 5, 9, 10, 22 can also be appreciated on CXR. Peak CXR severity score at 10-12 days after symptom onset is commensurate with previous findings on CT, where peak severity was reported at 6-11 days 8, 23 . The proportion of patients in our study exhibiting abnormal radiographic findings (51/64, 80%) is higher than that in the case series I n P r e s s of 9 patients published by Yoon et al. 21 (5/9, 56%) . Furthermore, CXR abnormalities were detectable in 6 patients whose initial RT-PCR was negative (6/64, 9%). Baseline CXR sensitivity was 69% [95% CI: 56-80%]. Albeit lower than the reported 97-98% sensitivity of CT 6,24 , our results suggest that CXR can play a role in the initial screening of COVID-19. Although further studies are needed, in the scenario where there is high clinical suspicion of COVID-19 it is conceivable that a positive CXR may obviate the need for a CT, thus reducing burden on CT units in this pandemic.

In our patient subgroup with both CXR and CT available (n=28), all positive CXRs were also positive on CT, and only 1 patient (1/4, 25%) had a falsely negative CXR when compared to CT. A major caveat is that during the study period, our institutions did not routinely perform CT for all COVID-19 patients. CT was performed later in the disease course (11 days on average) than CXR. CT was reserved for patients with clinical deterioration or poor response to treatment. Thus, the CT group in our study was likely skewed towards patients with more severe radiological manifestations.

The role of CXR in clinical monitoring is less clear. In our subgroups that were followed to both virologic (n=23) and radiographic (n=18) recovery, there was no statistically significant patients testing positive on RT-PCR again after discharge 25, 26 , our opinion is that imaging I n P r e s s should be used as an adjunct to clinical parameters in monitoring of disease course, until further evidence is available.

Our study has several limitations. First, not all patients were followed to their final outcome, thus correlation with disease course is truncated for some patients. The intervals between serial CXRs and RT-PCR testing were dictated by clinical need and not uniform, thus potentially affecting the precision of our analysis. Third, some of the radiographic features were subtle, which may limit reproducibility in suboptimal viewing conditions or by non-specialists. Fourth, there is a lack of a non-COVID-19 control group and CT was only available for a subgroup, thus limiting evaluation of the sensitivity and specificity of CXR.

In summary, we describe the features of COVID-19 on CXR, to complement the publications on CT. Baseline CXR had a sensitivity of 69% in our cohort. As the COVID-19 pandemic threatens to overwhelm healthcare systems worldwide, CXR may be considered as a tool for identifying COVID-19, but is less sensitive than CT. I n P r e s s I n P r e s s 

A Novel Coronavirus from Patients with Pneumonia in China

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

World Health Organization. Coronavirus Disease 2019 (COVID-19) Situation Report -51

World Health Organization. Coronavirus Disease 2019 (COVID-19) Situation Report -62

CT Features of Coronavirus Disease

Pneumonia in 62 Patients in Wuhan, China

Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases

COVID-19): Relationship to Duration of Infection

Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia. Radiology

Imaging Profile of the COVID-19 Infection: Radiologic Findings and Literature Review

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)

Chinese Society of Radiology. Chinese Society of Radiology. Radiological diagnosis of new coronavirus infected pneumonitis: Expert recommendation from the Chinese Society of Radiology

Coronavirus Disease 2019 (COVID-19): A Perspective I n P r e s s from China

Corona Virus International Public Health Emergencies: Implications for Radiology Management

Lessons from the frontline of the covid-19 outbreak -The BMJ

ACR Recommendations for the use of Chest Radiography and Computed Tomography (CT) for Suspected COVID-19 Infection | American College of Radiology

Statements/Recommendations-for-Chest-Radiography-and-CT-for-Suspected-COVID19-Infection

Imaging the coronavirus disease COVID-19

Government Centre for Health. Latest Situation of Cases of COVID-19

Fleischner Society: Glossary of terms for thoracic imaging

Severity scoring of lung oedema on the chest radiograph is associated with clinical outcomes in ARDS

Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens

Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19): Analysis of Nine Patients Treated in Korea

Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients

Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study

Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR. Radiology

Follow-Up Study of 131 COVID-19 Discharged Patients: Is the Current Chinese Discharge Criteria Reliable

Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China